Home > Healthcare > Medical Devices > Implantable Devices > Coronary Stents Market
Coronary Stents Market Analysis
- Report ID: GMI2966
- Published Date: Feb 2023
- Report Format: PDF
Coronary Stents Market Analysis
Coronary stents market share from the drug-eluting stent (DES) segment was valued at nearly USD 4.9 billion in 2022. The high growth rate is a result of the benefits of drug-eluting stents, which include better treatment results and a decreased re-obstruction rate, among other things. DES is employed in a variety of applications, including myocardial infarction and percutaneous coronary intervention. The addition of new and advanced drug-eluting stents is expected to fuel product demand.
Coronary stents market from the cardiac centers end-use segment is expected to witness a 5.1% CAGR between 2023 and 2032. The specialized cardiac centers reach a large patient population and are equipped with cutting-edge technologies and treatment alternatives. Efforts to improve patient care and well-being will boost product deployment across these centers. Patients that need long-term care and treatment tend to prefer cardiac centers as they have multiple treatment options and are equipped with advanced medical equipment.
Asia Pacific coronary stents market is expected to record a 6.2% CAGR during 2023 and 2032 due to the growing geriatric population in the region. The increase in the incidence rate of cardiovascular diseases, particularly coronary heart disease, is forecasted to influence market growth. For instance, the Technical Group on Population Projections for India and States 2011–2036 report estimates that there would be about 138 million elderly people in India by 2021 (67 million men and 71 million women), with an additional 56 million seniors predicted by 2031.
Frequently Asked Questions (FAQ) :
Coronary Stents Market Scope
